( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



*Husam A. Alaebe, Dr. Majid A. Maatook and Dr. Dhaighem E. Atwan


Type I diabetes mellitus is an autoimmune disease; it is one of most serious and common metabolic disorders in children and adolescents, in which the body immune system destroys the insulin releasing beta cells. Thus, the body cells cannot absorb glucose. Cytokines play a major role in the pathogenesis of autoimmune type I diabetes and in the initiation of β-cell damaging process. The objective of this study is to get more understanding about the role of cytokines in the development of beta cell destruction and immune state in T1DM patient, by measuring the IFN-γ, IL-6 and IL-10. A total of sixty patients with long standing autoimmune T1DM (diagnosed more than one year) were included in the study. Twenty eight healthy control subjects had the measurement of serum IL-6, IL-10 and IFN-γ by enzyme linked immunosorbent assay (ELISA) technique. Higher serum levels of IL-6 and IFN-γ were observed in the patients (224.02, 394.34 pg/ml respectively) compared to controls (164.65, 264.07 pg/ml respectively). The statistical analysis showed a significant difference between patients and controls (P= 0.0001, 0.017 respectively). A difference of the mean IL-6 concentration appears between patients in two age groups in T1DM age (1 -10 y) (P= 0.085). No significant differences appear in the mean between patients and controls for BMI and age (p= 0.865, 0.149 respectively). No significant difference appear in the serum level IL-6, IL.10 and IFN-γ between patients divided into two group according HbA1c (T1DM controlled) and (T1DM uncontrolled) (p=0.604, 0.423, 0.590). In long standing patients with autoimmune type I diabetes mellitus, clinical significant elevation in serum levels of IFN-γ and IL-6 while IL-10 serum level begin decline. A difference of mean IL-6 concentration appears between patients in both age groups T1DM age (1 -10 y). No significant differences appear in the mean serum concentrations of IFN-γ, IL.10 and IL-6 between patient and control for BMI and age. No significant difference appear in the serum level IFN-γ, IL-10 and IL-6 between patients divided into two groups according HbA1c (T1DM controlled) and (T1DM uncontrolled).

Keywords: .

[Full Text Article]




    December issue has been successfully launched on December 2023.

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 December 2023 Issue has been Published, Kindly check it on

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia